Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
RadNetMEX:RDNT 52 EV-to-FCF is 60.34 as of Jul. 24, 2026, which is 23% above its 10-year median of 49.00. GuruFocus rates MEX:RDNT with a GF Score™ of 52/100 and a GF Value™ of MXN1,324.50 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 100 Medical Diagnostics & Research companies, RadNet ranks worse than 78% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, RadNet's Enterprise Value is MXN113,984 Mil.
RadNet's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1,889 Mil. Therefore, RadNet's EV-to-FCF for today is 60.34.
The historical rank and industry rank for RadNet's EV-to-FCF or its related term are showing as below:
MEX:RDNT'
s EV-to-FCF Range Over the Past 10 Years
Min: -516.31 Med: 49 Max: 463.14
Current: 64.2
During the past 13 years, the highest EV-to-FCF of RadNet was 463.14. The lowest was -516.31. And the median was 49.00.
MEX:RDNT's EV-to-FCF is ranked worse than 78% of 100
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.57
vs MEX:RDNT: 64.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-24), RadNet's stock price is MXN1191.78.
RadNet's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-2.914. Therefore, RadNet's PE Ratio (TTM) for today is At Loss.
RadNet (MEX:RDNT) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
RadNet's share price for today is MXN1191.78.
RadNet's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-2.914.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
RadNet EV-to-FCF Related Terms
RadNet EV-to-FCF Historical Data
* Premium members only.
The historical data trend for RadNet's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, RadNet's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RadNet EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, RadNet's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where RadNet's EV-to-FCF falls into.
RadNet's current Enterprise Value is MXN113,984 Mil.
RadNet's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,889 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RadNet (MEX:RDNT) has a EV-to-FCF of 60.34 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on RadNet and its competitors. This is 23% above median its historical median of 49.00. According to the industry distribution chart, RadNet ranks #78 out of 100 companies in the Medical Diagnostics & Research industry, placing it in the top 78%.
Is RadNet's EV-to-FCF too high?
RadNet's current EV-to-FCF of 60.34 is 23% above median its 10-year median of 49.00. The Medical Diagnostics & Research industry median EV-to-FCF is 26.57. RadNet's value of 60.34 is 127.1% above this industry median. Based on the distribution chart, RadNet ranks #78 out of 100 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, RadNet has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does RadNet's EV-to-FCF compare to VCYT and SHC?
According to the Medical Diagnostics & Research industry distribution chart, RadNet ranks #78 out of 100 companies for EV-to-FCF. This places RadNet in the lower half of its industry. The industry median EV-to-FCF is 26.57. RadNet's value of 60.34 is 127.1% above this benchmark. While the company's 10-year median is 49.00 vs. the industry median of 26.57, RadNet has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 26.57, based on 100 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RadNet's current EV-to-FCF of 60.34 is 127.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on RadNet and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 26.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RadNet's current EV-to-FCF is 60.34, which is 23% above median its own 10-year median of 49.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RadNet stock overvalued right now?
Based on GuruFocus' analysis, RadNet (MEX:RDNT) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,324.50, compared to a current price of MXN1,191.78 — trading 10% below its estimated fair value. The current EV-to-FCF is 60.34, which is 23% above median its 10-year median of 49.00 and 127.1% above the Medical Diagnostics & Research industry median of 26.57. RadNet's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For RadNet (MEX:RDNT), the current EV-to-FCF is 60.34 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RadNet (MEX:RDNT) Overvalued in 2026?
Based on GuruFocus' analysis, RadNet stock appears to be undervalued.
The current stock price of MXN1,191.78 is trading 10% below its estimated GF Value™ of MXN1,324.50.
GuruFocus considers RadNet to be Modestly Undervalued.
Key valuation signals for MEX:RDNT:
EV-to-FCF: 60.34 (23% above median its 10-year median of 49.00)
GF Value™: MXN1,324.50 vs. price of MXN1,191.78 (10% below fair value)
Industry Position: 127.1% above the Medical Diagnostics & Research median (#78 of 100)
No single metric tells the full story. See the MEX:RDNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
52GF Score
Get the complete analysis for MEX:RDNT
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:RDNT has been successfully added to your 
